Related Experiment Video
Updated: Aug 13, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
[The kidney in dysproteinemia]
D Spanti1, C Marcantoni, D Di Landro
1U.O. di Nefrologia e Dialisi, Azienda Ospedaliera Cannizzaro, Catania.
Abstract:
Several renal diseases are associated with the dysproteinemias, and their pathogenesis is related to paraprotein deposits in the kidney: light chains can affect the kidney by a direct toxic effect on tubular cells, or by intratubular or tissue precipitation. Multiple myeloma (MM) is the most prevalent dysproteinemia, and the spectrum of associated renal diseases includes myeloma kidney (cast nephropathy), amyloidosis and monoclonal immunoglobulin deposition disease (MIDD). Renal failure is seen in approximately 50% of patients with MM at diagnosis, most frequently attributed to myeloma kidney. Renal function can recover in more than half the patients by prompt rehydration with intravenous fluids, to achieve a urine flow of >3 l/day, and by treating the hypercalcemia. Plasma exchange in combination with corticosteroids is suggested in patients with rapidly progressive renal failure. When renal failure is associated with MIDD or amyloidosis, renal function recovery is reduced to 10%, and patient survival is related to the entity of extrarenal tissue distribution of paraprotein deposits. Dialysis should be offered to patients with end-stage renal disease. High dose chemotherapy and autologous stem cells transplantion (SCT) is recommended in patients who do not have severe co-morbidities.
Insights
Dysproteinemias cause kidney damage through paraprotein deposits. Prompt treatment of multiple myeloma (MM)-related kidney failure improves outcomes, but recovery is limited in advanced cases like monoclonal immunoglobulin deposition disease (MIDD) or amyloidosis.
Area of Science:
- Nephrology
- Hematology
- Immunology
Context:
- Dysproteinemias, particularly multiple myeloma (MM), are linked to various kidney diseases.
- Paraprotein deposition in the kidney is a key pathogenic mechanism.
- Myeloma kidney (cast nephropathy), amyloidosis, and monoclonal immunoglobulin deposition disease (MIDD) are common renal complications.
Purpose:
- To summarize the spectrum of renal diseases associated with dysproteinemias.
- To outline the pathogenesis of paraprotein-related kidney injury.
- To review current management strategies and prognoses for renal failure in MM.
Summary:
- Renal failure affects about 50% of MM patients at diagnosis, primarily due to myeloma kidney.
- Prompt rehydration and hypercalcemia treatment can improve renal function in many cases.
- Plasma exchange, corticosteroids, dialysis, and stem cell transplantation (SCT) are treatment options depending on disease severity and type.
Impact:
- Highlights the significant impact of paraprotein deposition on renal health.
- Emphasizes the importance of early diagnosis and multidisciplinary management for MM-associated kidney disease.
- Provides insights into prognostic factors and therapeutic approaches for renal recovery and patient survival.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Nephrons
Acute Kidney Injury V: Interprofessional Care
Nephrotic Syndrome I : Introduction

